Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity.
about
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alphaTurning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsEpigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor HypoxiaEffects of histone deacetylase inhibitors on HIF-1The correlation between HER-2 expression and the CEUS and ARFI characteristics of breast cancer.Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumorsEffects of Trichostatin A on In vitro Development of Porcine Embryos Derived from Somatic Cell Nuclear TransferHypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyNew histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells.Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluationExploring the role of mitochondrial UQCRB in angiogenesis using small molecules.Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies.HIF-1α inhibition reduces nasal inflammation in a murine allergic rhinitis modelHistone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseasesHistone deacetylase inhibitors for treating a spectrum of diseases not related to cancerHistone deacetylase inhibitors in clinical development.Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activationOxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.Novel therapeutic agents for cutaneous T-Cell lymphoma.Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Development of novel therapeutic strategies that target HIF-1.Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells.Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenograftsInhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.Hypoxia and trophoblast differentiation: a key role for PPARγ.Targeting tumor angiogenesis with histone deacetylase inhibitors.Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi‑1 leukemia cells.Targeting the hypoxia-inducible factor (HIF) pathway in cancer.Transcriptome remodeling in hypoxic inflammation.Cancer stem cells: a new framework for the design of tumor therapies.Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions.Recent agents targeting HIF-1α for cancer therapy.HIFs, angiogenesis, and cancer.
P2860
Q24308024-1DBC42EA-7204-4341-A64F-6530DECDC11BQ26744212-AD8A1AED-4B46-4E4B-A70A-C15378F34535Q26783014-F891D868-B11E-4439-9FA7-0178C5105645Q28273896-2F9527DE-E3AB-486D-AC96-7F5A57B618C4Q30354502-562E989B-8543-4F3C-92E2-B560E4AA9AE8Q30459589-9D655934-863F-426F-BAEE-9238A43B62D4Q33235403-8E24DF6E-F6D2-48B3-9B52-6E0CF5EE5220Q33402040-3F7406C7-2982-4850-B6F0-FD5A46C3B179Q33883997-0C879895-9571-4F5A-9E0D-6690FD957894Q33950665-EB90F53B-C57D-4116-A9C2-BF98CC37D5C4Q34101029-0D23E1EA-D3F6-478D-93F5-EA1FE297218AQ34102029-3777B501-C5C3-45B8-B65A-87AF9E1C7F3CQ34332044-3443A729-316A-497C-ABEE-BC37008A2A0BQ34382527-27B12C54-ACA5-4DEE-A7E5-B7DC757BC030Q34399444-556EDA54-1FB8-4414-9F89-ED509391D705Q34469780-C67A9A78-AAE9-4A70-9D28-725E25B338A1Q34519869-B7473E51-A441-47A3-89AB-AE87F4FE5F92Q34657382-AE503CB0-24B1-4D48-BDB5-B323FF6B0E2BQ35016934-697AB32A-FB26-41FE-AE3C-375D48985449Q35609717-62B4ABF2-AD7D-4CEB-AAE3-118EE480582CQ35622038-3D406BF3-875E-4D4C-9920-B9B0D7396B7DQ35841917-64EA8FFD-F24C-4BB3-915E-370545487930Q36052572-D4E2B516-3E0C-4E5C-B13A-1FEC809BA34AQ36161365-7DADE313-354F-48FC-B491-EF36DF2B5F88Q36179533-FA8F2B81-ACB3-47C8-82BC-D070BB9CCAA1Q36425968-D5486D30-5115-49F1-9068-F1B2AFB2DD25Q36470446-36E2C2BF-A213-4F5C-A3B4-1163B1A8E629Q36528232-767BEE80-D5BB-4631-9526-0CD7F9767D34Q37024427-68F82FDA-5317-4666-9B71-6B4064014B09Q37244683-A7929AC3-A4DF-41F1-AF75-ED5944F027CDQ37359115-DA0CEEB9-43A1-4B58-BCA7-F73E3F15594BQ37496300-C82949FC-18CB-4CF5-A6BE-A30C9C2DF795Q37587446-C8537182-089E-4F94-9FB8-3EA008E7F3A6Q37720331-BE7B2FC4-6653-40EA-B99F-71519AEFC19AQ37796629-88B9B948-94F3-48A0-85BE-56F33613E651Q37810272-BDDDBA76-0CA9-4AAE-9B70-8C1D751C9E02Q37943792-E5AF677B-BFC0-4052-A2CA-F2BF872CA4C8Q38003390-243A880A-2AAA-476E-A0E5-2585B35CCE54Q38042021-8A93BDB7-CAD8-4225-AB1C-4B41BB5BE5E6Q38066120-F1F8AB42-D90A-4E70-9DBB-2108A387E2D2
P2860
Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@en
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@nl
type
label
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@en
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@nl
prefLabel
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@en
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@nl
P2093
P1476
Inhibition of hypoxia-induced ...... ession of HIF-1alpha activity.
@en
P2093
Hae-Sun Kim
Hidenori Nakajima
Ho Jeong Kwon
Kyu-Won Kim
Myung Jin Son
Se-Hee Kim
You Mie Lee
P304
P356
10.1016/S0006-291X(02)02787-0
P407
P577
2003-01-01T00:00:00Z